Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of two doses of sublingual immunotherapy
(SLIT) administered as allergen-based tablets once daily over a period of 12 months compared
to placebo, for reduction of allergic rhinitis symptoms and rescue medication usage